Trough anti-Xa activity after intermediate dose nadroparin for thrombosis prophylaxis in critically ill patients with COVID-19 and acute kidney injury
Article in Scientific Reports (October 2022)
The most recent citing publications are shown below. View all 10 publications that cite this research output on Dimensions.
Pharmacokinetic profiles of intravenous versus subcutaneous administration of low molecular weight heparin for thromboprophylaxis in critically ill patients: A randomized controlled trial
Article in Journal of Critical Care (April 2022)
Comparing effects of different routes of heparin administration on the serum biomarkers of thrombosis
Article in Journal of Comparative Effectiveness Research (April 2016)